Solitaire Stent Reduced Disability in Stroke Patients in the SWIFT PRIME Trial. Issue 2 (11th March 2015)

• Record Type: Journal Article
• Authors: Zarifyan, Alla
• Other Names: Saver Jeffrey L. presenter.
• Is Part Of: MD conference express. Volume 15:Issue 2(2015)
• Page Start: 15
• Page End: 16
• Publication Date: 2015-03-11
• Subjects: acute ischemic stroke -- disability -- endovascular -- reperfusion -- Solitaire -- stent -- SWIFT PRIME -- tPA; Medicine -- Congresses; 610
• DOI: 10.1177/1559897715578114
• Languages: English
• ISSNs: 1559-8977

Abstract

The SWIFT PRIME study demonstrated that the Solitaire stent was safe and effective at reducing poststroke disability in patients with acute ischemic stroke. Functional independence (mRS of 0 to 2) at 90 days was achieved in 60.2% of patients in the Solitaire plus IV tPA group vs 35.5% in the IV tPA group ( P < .0008).